- Home
- LPCN vs PRPH Comparison
LPCN vs PRPH Comparison
Compare LPCN & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- PRPH
- Stock Information
- Founded
- LPCN 1997
- PRPH 1989
- Country
- LPCN United States
- PRPH United States
- Employees
- LPCN N/A
- PRPH N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- LPCN Health Care
- PRPH Health Care
- Exchange
- LPCN Nasdaq
- PRPH Nasdaq
- Market Cap
- LPCN 16.1M
- PRPH 15.2M
- IPO Year
- LPCN N/A
- PRPH 1997
- Fundamental
- Price
- LPCN $3.29
- PRPH $0.37
- Analyst Decision
- LPCN Strong Buy
- PRPH
- Analyst Count
- LPCN 2
- PRPH 0
- Target Price
- LPCN $9.00
- PRPH N/A
- AVG Volume (30 Days)
- LPCN 59.4K
- PRPH 4.1M
- Earning Date
- LPCN 08-07-2025
- PRPH 08-13-2025
- Dividend Yield
- LPCN N/A
- PRPH N/A
- EPS Growth
- LPCN N/A
- PRPH N/A
- EPS
- LPCN N/A
- PRPH N/A
- Revenue
- LPCN $3,674,834.00
- PRPH $5,845,000.00
- Revenue This Year
- LPCN N/A
- PRPH $221.82
- Revenue Next Year
- LPCN N/A
- PRPH N/A
- P/E Ratio
- LPCN N/A
- PRPH N/A
- Revenue Growth
- LPCN N/A
- PRPH N/A
- 52 Week Low
- LPCN $2.68
- PRPH $0.22
- 52 Week High
- LPCN $8.71
- PRPH $4.33
- Technical
- Relative Strength Index (RSI)
- LPCN 51.52
- PRPH 53.41
- Support Level
- LPCN $3.13
- PRPH $0.32
- Resistance Level
- LPCN $3.53
- PRPH $0.37
- Average True Range (ATR)
- LPCN 0.24
- PRPH 0.03
- MACD
- LPCN 0.01
- PRPH -0.00
- Stochastic Oscillator
- LPCN 48.33
- PRPH 50.00
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.